Sunil K Nadar is a Consultant Cardiologist at Sultan Qaboos University Hospital in Muscat, Oman. Prior to this he worked as a Consultant Cardiologist at the NHS in Birmingham, UK. He did his research MD on platelet activation in hypertension and completed his specialist cardiology training in the West Midlands, UK. Dr Nadar is a Co-Editor with the Journal of Human Hypertension and an Associate Editor with the Sultan Qaboos University Medical Journal. He is currently involved in research work investigating the effects of thalassemia on the heart, the psychological impact of admission on patients with heart disease, and community awareness of the dangers of high dietary salt intake. He is also the coordinator for the May Measurement Month programme in Oman.

Gregory Y.H. Lip, is Price-Evans Chair of Cardiovascular Medicine at the University of Liverpool and Director of the Liverpool Centre for Cardiovascular Science at the University of Liverpool and Liverpool Heart & Chest Hospital, UK. He is also Distinguished Professor at Aalborg University, Denmark, and Adjunct Professor at Seoul National University and Yonsei University, Seoul, Korea. In 2014 Professor Lip was ranked by Expertscape as the world's leading expert in the understanding and treatment of Atrial Fibrillation. He was on the writing committee for various international guidelines and has acted at a senior editorial level for major international textbooks and journals. Professor Lip's current research interests range from epidemiology to pathophysiology, translational research, clinical risk assessment and trajectories of risk, patient management pathways, and applied health research.

• Part 1: Epidemiology, pathogenesis and diagnosis


• 1: Sunil K. Nadar and Stephanie Harrison: Epidemiology of hypertension


• 2: Sheon Mary, Giacomo Rossitto, and Christian Delles: Pathophysiology of hypertension


• 3: Gurbhej Singh and Gurpreet Wander: Secondary hypertension


• 4: Martin Wolley and Michael Stowasser: Diagnosis and investigation of hypertension


• Part 2: Complications of hypertension


• 5: Thomas Salmon, James Hatherley, and Rajiv Sankaranarayanan: Hypertension: a cardiovascular risk factor


• 6: Yuichiro Yano and Sunil K. Nadar: Left ventricular hypertrophy


• 7: Mohammed Najeeb Al-Rawahi: Atrial fibrillation and hypertension


• 8: Arun R. Gujjar: The brain in Hypertension


• 9: Sarah Ahmad and Jordana B. Cohen: The kidneys in hypertension


• 10: Peck Lin Lip: The eye in hypertension


• Part 3: Management of hypertension


• 11: Gregory Y.H. Lip and Sunil K. Nadar: Overview of the guidelines on the management of hypertension


• 12: James P. Sheppard and Sunil K. Nadar: Hypertension and cardiovascular risk management


• 13: Benjamin J.R. Buckley and Stephanie J. Finnie: Non-pharmacological management of hypertension


• 14: Harsh Goel and Ashish Kumar: Diuretics in hypertension


• 15: Hatim Al Lawati: Beta blockers in hypertension


• 16: Stefanie Lip and Sandosh Padmanabhan: Calcium channel blockers and hypertension


• 17: Ify R. Mordi and Chim C. Lang: Blockers of the Renin- Angiotensin- Aldosterone system in hypertension


• 18: Shankar Patil, Muzahir Tayebjee, and Sunil K. Nadar: Other antihypertensive agents


• 19: Vikas Kapil: Renal denervation


• 20: Hassan Al-Riyami and Dierdre A. Lane: Improving medication adherence in hypertension


• Part 4: Special conditions


• 21: Gloria Valdés: Hypertension in pregnancy: Physiopathological, preventive, therapeutic and long-term considerations


• 22: Alena Shantsila: Hypertensive emergencies


• 23: Asangaedem Akpan: Treatment of the older adult


• 24: Fang-Fei Wei, Chen Liu, and Jan A. Staessen: Diagnosis and management of resistant hypertension


• 25: Daniel J. Cuthbertson: Hypertension in patients with diabetes mellitus